Abouljoud MS - Search Results

1

Nagai S, Abouljoud MS, Moonka D, Yoshida A. Nagai S, et al. Among authors: abouljoud ms. Transplantation. 2014 Mar 27;97(6):e33-4. doi: 10.1097/TP.0000000000000035. Transplantation. 2014. PMID: 24637871 No abstract available.

2

Quantitation of hepatitis C virus RNA in liver tissue of allografts: correlation with histologic features and liver function tests.

Aardema KL, Nakhleh RE, Terry LK, Burd EM, Ma CK, Moonka DK, Brown KA, Abouljoud MS. Aardema KL, et al. Among authors: abouljoud ms. Transplant Proc. 1999 Feb-Mar;31(1-2):477-8. doi: 10.1016/s0041-1345(98)01716-3. Transplant Proc. 1999. PMID: 10083198 No abstract available.

3

Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants.

Aardema KL, Nakhleh RE, Terry LK, Burd EM, Ma CK, Moonka DK, Brown KA, Abouljoud MS. Aardema KL, et al. Among authors: abouljoud ms. Mod Pathol. 1999 Nov;12(11):1043-9. Mod Pathol. 1999. PMID: 10574601

4

High levels of hepatitis C virus RNA in native livers correlate with the development of cholestatic hepatitis in liver allografts and a poor outcome.

Deshpande V, Burd E, Aardema KL, Ma CK, Moonka DK, Brown KA, Abouljoud MS, Nakhleh RE. Deshpande V, et al. Among authors: abouljoud ms. Liver Transpl. 2001 Feb;7(2):118-24. doi: 10.1053/jlts.2001.21278. Liver Transpl. 2001. PMID: 11172395 Free article.

5

The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C.

Gottschlich MJ, Aardema KL, Burd EM, Nakhleh RE, Brown KA, Abouljoud MS, Hirst K, Moonka DK. Gottschlich MJ, et al. Among authors: abouljoud ms. Liver Transpl. 2001 May;7(5):436-41. doi: 10.1053/jlts.2001.23909. Liver Transpl. 2001. PMID: 11349265 Free article.

6

Successful strategy for reducing biliary complications after liver transplantation.

Abouljoud MS, Escobar F, Douzdjian V, Moonka D, Shick L, Brown KA. Abouljoud MS, et al. Transplant Proc. 2001 Aug;33(5):2714-5. doi: 10.1016/s0041-1345(01)02158-3. Transplant Proc. 2001. PMID: 11498136 No abstract available.

7

Recurrent disease after liver transplantation.

Abouljoud MS, Escobar F, Douzdjian V, Bajjoka I, Moonka D, Shick L, Brown KA. Abouljoud MS, et al. Transplant Proc. 2001 Aug;33(5):2716-9. doi: 10.1016/s0041-1345(01)02159-5. Transplant Proc. 2001. PMID: 11498137 Review. No abstract available.

8

Living donor and split-liver transplantation: an overview.

Abouljoud M, Yoshida A, Dagher F, Moonka D, Brown K. Abouljoud M, et al. Transplant Proc. 2003 Nov;35(7):2772-4. doi: 10.1016/j.transproceed.2003.08.067. Transplant Proc. 2003. PMID: 14612114 Review. No abstract available.

9

The efficacy and limitations of sirolimus conversion in liver transplant patients who develop renal dysfunction on calcineurin inhibitors.

Lam P, Yoshida A, Brown K, Abouljoud M, Bajjoka I, Dagher F, Moonka DK. Lam P, et al. Dig Dis Sci. 2004 Jun;49(6):1029-35. doi: 10.1023/b:ddas.0000034567.53748.df. Dig Dis Sci. 2004. PMID: 15309896 Clinical Trial.

10

Rapid progression of native renal artery fibromuscular dysplasia following kidney donation.

Parasuraman R, Attallah N, Venkat KK, Yoshida A, Abouljoud M, Khanal S, Greenbaum A. Parasuraman R, et al. Am J Transplant. 2004 Nov;4(11):1910-4. doi: 10.1111/j.1600-6143.2004.00581.x. Am J Transplant. 2004. PMID: 15476494 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters